EDGAR Filing Documents for 0001193125-21-296921

Form 8-K - Current report:

SEC Accession No. 0001193125-21-296921

Filing Date

2021-10-12

Accepted

2021-10-12 16:31:21

Documents

Period of Report

2021-10-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d229488d8k.htm	8-K	37722
2	EX-1.1	d229488dex11.htm	EX-1.1	216412
3	EX-3.1	d229488dex31.htm	EX-3.1	73390
4	EX-4.1	d229488dex41.htm	EX-4.1	121176
5	EX-10.1	d229488dex101.htm	EX-10.1	51451
6	EX-10.2	d229488dex102.htm	EX-10.2	67629
7	EX-10.3	d229488dex103.htm	EX-10.3	101210
8	EX-10.4	d229488dex104.htm	EX-10.4	51638
9	EX-10.5	d229488dex105.htm	EX-10.5	53611
10	EX-10.6	d229488dex106.htm	EX-10.6	53441
11	EX-10.7	d229488dex107.htm	EX-10.7	9728
12	EX-99.1	d229488dex991.htm	EX-99.1	4739
13	EX-99.2	d229488dex992.htm	EX-99.2	4395
	Complete submission text file	0001193125-21-296921.txt		847931

Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103

Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450

PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)